Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
The global prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has reached alarming levels, affecting nearly one-third of the world's population. This review analyzes current evidence on the intricate relationships between MASLD, insulin resistance, and type 2 diabete...
Saved in:
| Main Authors: | Ankita Dua, Rashmi Kumari, Mona Singh, Roushan Kumar, Sunila Pradeep, Akinyemi I. Ojesina, Roshan Kumar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1618275/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
by: Natchaya Polpichai, et al.
Published: (2024-12-01) -
Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease
by: Adeyinka Taiwo, et al.
Published: (2025-06-01) -
Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis
by: Like Zhou, et al.
Published: (2025-01-01) -
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease
by: Bridget M. Geyer, et al.
Published: (2025-01-01) -
Circulating Asprosin and Neuregulin-4 in metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
by: Roshan Kumar Mahat, et al.
Published: (2025-05-01)